Kronos Bio/$KRON
About Kronos Bio
Ticker
Industry
Employees
Kronos Bio Metrics
$57M
-
-$1.44
1.86
-
Price and volume
Market cap
$57M
Beta
1.86
52-week high
$1.60
52-week low
$0.69
Average daily volume
388K
Financial strength
Current ratio
8.316
Quick ratio
8.117
Long term debt to equity
20.282
Total debt to equity
23.215
Interest coverage (TTM)
-46.83%
Management effectiveness
Return on assets (TTM)
-25.13%
Return on equity (TTM)
-59.08%
Valuation
Price to revenue (TTM)
5.737
Price to book
0.52
Price to tangible book (TTM)
0.52
Price to free cash flow (TTM)
-0.729
Growth
Revenue change (TTM)
146.48%
Earnings per share change (TTM)
-30.87%
3-year earnings per share growth (CAGR)
-14.63%
What the Analysts think about Kronos Bio
Analyst Ratings
Kronos Bio Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Kronos Bio Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Kronos Bio News
Kronos Bio Announces CEO Transition and Reduction in Force
Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
FAQs
What’s the current market cap for Kronos Bio stock?
What is the P/E ratio for Kronos Bio stock?
Does Kronos Bio stock pay dividends?
No, Kronos Bio (KRON) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Kronos Bio dividend payment date?
Kronos Bio (KRON) stock does not pay dividends to its shareholders.
What is the beta indicator for Kronos Bio?
Kronos Bio (KRON) has a beta rating of 1.86. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.